Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial

NCT06972680 is registered in ClinicalTrials.gov with Affiliated Hospital of Jiaxing University as lead sponsor.

NCT NCT06972680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06972680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial
Lead sponsor
Affiliated Hospital of Jiaxing University
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 1, 2025
Completion date
December 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

shoulder arthroscopy